FILING ANALYSIS · MONDAY, OCTOBER 5
NEUROONE MEDICAL TECHNOLOGIES Corp NMTC — 8-K: Results of Operations and Financial Condition
neutral
The company reported preliminary annual revenue of $10.5 million and a record $4.5 million purchase order, but the information is subject to change and has not been audited, and the company faces various risks and uncertainties that may impact its future results.
The filing
8-K - NEUROONE MEDICAL TECHNOLOGIES Corp (0001500198) (Filer)
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →